Human Alzheimer's Serum

<strong>Human Alzheimer's Serum</strong>_x000D_ <strong>Catalog number:</strong> B2012894S_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 0.5-1.0 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Serum_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Single Donor Human Alzheimer's Serum_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Chen X, Sun G, Tian E, Zhang M, Davtyan H, Beach TG, Reiman EM, Blurton-Jones M, Holtzman DM, Shi Y. Modeling Sporadic Alzheimer's Disease in Human Brain Organoids under Serum Exposure Adv Sci (Weinh). 2021 Sep;8(18):e2101462._x000D_ 2: Lashley T, Schott JM, Weston P, Murray CE, Wellington H, Keshavan A, Foti SC, Foiani M, Toombs J, Rohrer JD, Heslegrave A, Zetterberg H. Molecular biomarkers of Alzheimer's disease: progress and prospects Dis Model Mech. 2018 May 8;11(5):dmm031781._x000D_ 3: Ide M, Harris M, Stevens A, Sussams R, Hopkins V, Culliford D, Fuller J, Ibbett P, Raybould R, Thomas R, Puenter U, Teeling J, Perry VH, Holmes C. Periodontitis and Cognitive Decline in Alzheimer's Disease PLoS One. 2016 Mar 10;11(3):e0151081._x000D_ 4: Amidfar M, de Oliveira J, Kucharska E, Budni J, Kim YK. The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease Life Sci. 2020 Sep 15;257:118020._x000D_ 5: Larsson SC, Traylor M, Malik R, Dichgans M, Burgess S, Markus HS; CoSTREAM Consortium, on behalf of the International Genomics of Alzheimer’s Project. Modifiable pathways in Alzheimer's disease: Mendelian randomisation analysis BMJ. 2017 Dec 6;359:j5375._x000D_ 6: Wolinsky D, Drake K, Bostwick J. Diagnosis and Management of Neuropsychiatric Symptoms in Alzheimer's Disease Curr Psychiatry Rep. 2018 Oct 27;20(12):117._x000D_ 7: Loera-Valencia R, Goikolea J, Parrado-Fernandez C, Merino-Serrais P, Maioli S. Alterations in cholesterol metabolism as a risk factor for developing Alzheimer's disease: Potential novel targets for treatment J Steroid Biochem Mol Biol. 2019 Jun;190:104-114._x000D_ 8: Liu S, Fan M, Zheng Q, Hao S, Yang L, Xia Q, Qi C, Ge J. MicroRNAs in Alzheimer's disease: Potential diagnostic markers and therapeutic targets Biomed Pharmacother. 2022 Apr;148:112681._x000D_ 9: Huo Z, Yu L, Yang J, Zhu Y, Bennett DA, Zhao J. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis Neurobiol Aging. 2020 Feb;86:123-133._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/34101780">10: Chen H, Liu S, Ge B, Zhou D, Li M, Li W, Ma F, Liu Z, Ji Y, Huang G. Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer's Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial J Prev Alzheimers Dis. 2021;8(3):249-256. </a>_x000D_ _x000D_ <strong>Products Related to Human Alzheimer's Serum can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>